A Phase 3, Multi-National, Double-Blind, Randomized, Placebo-Controlled, Stratified, Parallel Group, Study to Evaluate the Safety, Tolerabiliity and Efficacy of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis ( ALS)

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Stanley Bedlack Neurology, Neuromuscular Disease

Administered By

Neurology

Awarded By

Cytokinetics, Inc.

Start Date

July 1, 2015

End Date

April 11, 2018

Administered By

Neurology

Awarded By

Cytokinetics, Inc.

Start Date

July 1, 2015

End Date

April 11, 2018